LINC01054

Across TCGA pan-cancer cohorts, LINC01054 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC01054 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC01054 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01054 expression acts as an unfavorable survival marker, although some lineages such as READ and ACC show a favorable association.

THCA, LIHC, and UVM are the cancer types where LINC01054 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.945	1.000	<.001	64	view →
LIHC	OS	Tertile	II,III,IV	0.207	0.485	.003	49	view →
UVM	OS	Tertile	All	0.321	0.695	.028	36	view →
ESCA	DFS	Quartile	All	0.387	0.607	.004	25	view →
KICH	OS	Quartile	II,III,IV	0.176	0.925	<.001	22	view →
SARC	OS	Quartile	All	0.369	0.701	.005	17	view →
READ	OS	Tertile	II,III,IV	1.000	0.472	.006	16	view →
ACC	DFS	Median	III,IV	0.553	0.181	.006	13	view →
DLBC	DFS	Tertile	All	0.406	0.889	.008	12	view →
UCEC	DFS	Tertile	IV	1.000	0.623	.035	12	view →
GBM	OS	Tertile	All	0.343	0.458	.034	5	view →
BRCA	OS	Quartile	II,III,IV	0.873	0.922	.032	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC01054–THCA (OS)

Open the THCA breakdown →